Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305848 · ClinicalTrials.gov registry record · Phase 4
Esophageal Food Impaction
A Phase 4 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03305848 is a Phase 4 study that has completed, run by HealthPartners Institute. The registered enrollment target is 20 participants.
The verdict
NCT03305848, a Phase 4 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is designed to obtain data on the safety and efficacy of oral nitroglycerin solution for the treatment of esophageal food impaction in patients presenting to the Emergency Department with presumed esophageal food impaction. The main hypothesis is to determine the success rate of oral nitroglycerin solution in relieving the food impaction by assessing the resolution of symptoms and the ability of the patient to swallow.
Interventions
- DRUG Nitrostat 0.4Mg Sublingual Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-08-25 |
| Est. Completion | 2019-04-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305848
The ClinicalTrials.gov registry entry for NCT03305848 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitrostat 0.4Mg Sublingual Tablet is the first listed.
NCT03305848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305848 about?
NCT03305848 is a clinical study titled "Esophageal Food Impaction". This study is designed to obtain data on the safety and efficacy of oral nitroglycerin solution for the treatment of esophageal food impaction in patients presenting to the Emergency Department with presumed esophageal food impaction. The main hypothesis is to determine the success rate of oral nitr...
What is the current status of trial NCT03305848?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2017-08-25. Estimated completion is 2019-04-04.
What interventions are being tested in trial NCT03305848?
The interventions under investigation include: Nitrostat 0.4Mg Sublingual Tablet (DRUG).
Who is sponsoring clinical trial NCT03305848?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.